Table 1 Main clinicopathological data.
From: Novel insights into the BAP1-inactivated melanocytic tumor
Clinical data | Frequency |
|---|---|
Gender distribution | |
Male | 11 |
Female | 25 |
Age, yrs | |
Range | 7–81 |
Mean | 30.4 |
Median | 25 |
Size (mm) | |
Range | 0.2–1.2 |
Mean | 0.6 |
Median | 0.5 |
Location | |
Head/Neck | 19 |
Trunk | 24 |
Upper extremities | 3 |
Genital area | 1 |
Unknown | 3 |
Personal (p) or family (f) history of malignancies | |
Multiple BIMTs (patients) | 8 |
Uveal melanoma (p) | 1 |
Cutaneous melanoma (p) | 5 |
Mesothelioma (p) | 1 |
Renal cell carcinoma (p&f) | 3 |
Colorectal carcinoma (f) | 3 |
Lung& bronchial cancer (p&f) | 3 |
Prostata carcinoma (f) | 2 |
Breast cancer (p) | 1 |
Leukemia (f) | 1 |
Schwannoma (p) | 1 |
Thyroid cancer (p) | 1 |
Renal cell carcinoma (f) | 1 |
Gynecological malignancy, NS (f) | 1 |
Unknown (f) | 15 |
Follow-up (months) | |
Range | 6–106 |
Mean | 34.3 |
Median | 30 |
